LidoXib (MAS Management Group)
Welcome to the PulseAid listing for the LidoXib drug offered from MAS Management Group. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | MAS Management Group |
NON-PROPRIETARY NAME: | Celecoxib, Lidocaine, Menthol |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2015-06-03 |
END MARKETING DATE: | 0000-00-00 |
LidoXib HUMAN PRESCRIPTION DRUG Details:
Item Description | LidoXib from MAS Management Group |
LABELER NAME: | MAS Management Group |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2015-06-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69677-060_59b9d247-4ea1-54a3-e053-2a91aa0a1ad1 |
PRODUCT NDC: | 69677-060 |
APPLICATION NUMBER: |